Overview / Abstract: |
STATEMENT OF NEED Immune thrombocytopenia (ITP) is a heterogeneous disorder with variable clinical features that range from asymptomatic thrombocytopenia to bothersome bruising to life-threatening intracranial hemorrhage. The lack of specific diagnostic criteria remains an important unmet need. Bleeding events are the most common clinical manifestation of ITP but are unpredictable with current laboratory testing. Many patients do not exhibit significant bleeding even in the setting of severe thrombocytopenia. While bleeding is an indication for treatment, clinical management is often influenced by other considerations, including tolerability of therapy, comorbidities with a predisposition to bleeding, the need for interventions that may cause bleeding, complications of specific therapies, accessibility of care, and patient factors (eg, worry or anxiety about disease burden, activity level, lifestyle). For this reason, the goals of therapy and/or efficacy measures of treatment response can vary significantly between patients. TARGET AUDIENCE Hematology/oncology physicians, oncology advanced practitioners, oncology nurses, and other health care professionals involved in the treatment of patients with ITP. LEARNING OBJECTIVES Upon completion of this activity, participants should be able to: 1. Discuss the pathogenesis of ITP and mechanisms of therapeutic strategies |
Expiration |
Nov 05, 2020 |
Discipline(s) |
Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME |
Format |
Monograph, Online |
Credits / Hours |
1.0 |
Accreditation |
ACCME, ANCC |
Presenters / Authors / Faculty |
James B. Bussel, MD (Chairperson) Allison Miller Imahiyerobo, APN |
Sponsors / Supporters / Grant Providers |
This activity is supported by an independent educational grant from Amgen. |
Keywords / Search Terms |
i3 Health i3 Health, immune thrombocytopenia, hematologic malignancies, hematology, hematology/oncology, ITP, CME, CNE, free CME, free CNE Free CE CME |